Lose Fat While Gaining Muscle (Proven by DEXA)

Key takeaways (fat loss + muscle gain)

• It’s possible to reduce body fat while building muscle because the body can supply materials for muscle while breaking down fat, even within relatively shorter time windows.
• The video uses an example (Nicholas N.) and argues that increasingly advanced tools can raise the “ceiling” beyond typical natural limits.

---

Wellness / lifestyle foundation (“Natti”): FSB = Sleep, Power, Protein

FSB framework

Sleep

• Deep sleep (stages 3–4) supports growth hormone release.
• Growth hormone is discussed as helping both muscle gain and burning visceral fat.
• Muscle-growth–related peptides are claimed to connect to this mechanism, and deep sleep quality may influence it.

Power (strength training)

• Recommended 2–3 strength sessions per week.
• Use progressive overload (“a little more, a little more”).
• Intensity guideline:
  • Most hard sets around RPE 7–9 (0–10 scale; 10 = max effort).
  • Occasional approaches to failure may be used.
• Mechanism described:
  • Hard training creates micro-damage → repair + satellite stem cell activation → nuclei donation to muscle fibers → hypertrophy.

Protein

• Target range: 1.6–2.2 g protein/kg body weight (more may bring diminishing returns).
• Whole eggs are highlighted:
  • Whole eggs > egg whites per gram-for-gram for muscle growth (yolk nutrients/fats are discussed as supporting anabolic processes).

Boundary / caution

• Natural methods have limits because recovery capacity eventually becomes the bottleneck.
• Overtraining is described as potentially harming:
  • hormones (testosterone, cortisol, thyroid),
  • and negatively impacting bone health and cardiovascular health.
• Core message: fundamentals matter, but they don’t scale infinitely.

---

“Next level” tools (exist today): raise the ceiling with pharmacology/biotech

Framed as “tools” that may be accessed via prescriptions, trials, clinics, or biohacker use. The video repeatedly emphasizes skepticism and physician oversight for some items.

5-Amino-1MQ (NNMT inhibitor) — theory: preserve NAD, improve performance

• Mechanism discussed
  • NNMT is framed as a metabolic drain that depletes NAD.
  • 5-amino-1MQ is purported to inhibit NNMT, reducing “metabolic leakage” and preserving NAD for energy, repair, and growth.
• Preclinical results claimed
  • In mice: improved grip strength; effects were additive when combined with exercise.
  • Reduced muscle fat deposits and supported muscle stem cell activation / muscle growth.
• Human evidence caveat
  • The video claims no double-blind randomized controlled human trials were shown by the narrator.
• Practical note
  • Mentions a link and discount code (“Stay Curious”), while urging viewers to research before spending.

ATX-304 (AMKP activator) — “metabolic furnace” approach

• Mechanism discussed
  • Activates AMPK, a key regulator also activated by fasting, ketosis, and exercise.
  • Intended to shift body priority toward energy production.
• Animal findings claimed
  • In obese, high-fat/sugar mice: drug groups gained less weight.
  • A “yo-yo” effect: reversing which group received ATX-304 reversed weight changes.
  • Reported fat loss without muscle loss in another study (100% of described weight loss as fat mass).
• Human status claimed
  • Phase 2 completed; early benefits for blood sugar and vascular health.
  • The video suggests specific body-composition targeting in humans is not established within the content.

Muscle peptides (injections) — growth hormone–axis stimulation

Common theme

• Peptides are described as acting via the growth hormone system to support:
  • muscle protein synthesis,
  • and reductions in visceral fat.

Growth hormone axis refresher (as stated)

• Brain secretes GHRH → pituitary releases growth hormone → downstream effects on muscle building and visceral fat breakdown.

CJC-1295 + Ipamorelin (popular combo)

• CJC-1295
  • Described as a GHRH analogue (“gas pedal”): enhances natural growth hormone signaling via pituitary pulses (not direct HGH injection).
• Ipamorelin
  • “Foot off the brake” via somatostatin pathway effects (simplified explanation).
• Safety/usage caveat
  • The narrator declines to provide exact dosages on YouTube due to prescription status and the need for doctor supervision.
• Additional mentions
  • A transformation story/photo is referenced involving Matt Mazeo (NOHO Labs CEO/co-founder).

Tesamorelin

• Similar goal: stimulate growth hormone production.
• Emphasized as more thoroughly studied, especially for visceral fat reduction.
• Evidence described
  • Double-blind RCTs reporting ~20% visceral fat reduction vs placebo.
  • Mentioned as FDA-approved for certain populations (not fully specified in the video summary).

---

“New frontier” (not yet widely available): releasing biologic brakes on muscle growth

Myostatin / activin A pathway inhibition (plus possible combo with GLP-1s)

• Concept
  • Biology includes “brakes” on muscle growth (energy conservation).
  • Redundant systems include myostatin and activin A pathways.
• Preclinical example claimed
  • Monkeys treated with inhibitors: ~30% fat mass reduction + ~10% muscle mass increase.
• Combination strategy discussed
  • Pair muscle-growth inhibitors with GLP-1 receptor agonists (e.g., Ozempic/Wegovy).
  • Claimed monkey results: ~50% fat mass decrease while muscle still increases (~6%).
• Human trial claim
  • A randomized placebo-controlled study: single dose led to ~3 kg muscle gain and ~4 kg fat loss over 8 weeks.
  • Side effects reported: headache, nausea, urinary tract infections.
  • Presented as not ready for mass adoption, but actively in clinical trials.

---

Overall “self-optimization” stance (important framing)

• The video emphasizes a non-prescriptive message:
  • Don’t treat it like a “run out and try everything” plan.
  • The narrator claims personal experimentation but prioritizes being healthy and functional.
• Presented philosophy:
  • Use tools to support freedom of action and empowerment, not to chase extremes.
• It also suggests the “best” approach depends on your starting point:
  • training status, starting body fat, and baseline diet.

---

Presenters / sources

• Presenter / narrator: Not explicitly named in the subtitles (repeatedly references “me” and “Stay Curious Metabolism”; provides links and discount code “Stay Curious”).
• Named example participant: Nicholas N. (from the “Stay Curious Metabolism” community).
• Featured individual for peptide transformation example: Matt Mazeo (NOHO Labs CEO and co-founder).
• Source organization mentioned: Stay Curious Metabolism (and Stay Curious Metabolism newsletter).